PMA device
ColoHealth
New Day Diagnostics, LLC · System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection (PHP, Class III) · First FDA decision Mar 19, 2025, newest Mar 19, 2025Colorectal cancer and polyps
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "ColoHealth"
MAUDE reports
0
Brand "ColoHealth", since 2015
PubMed studies
0
Mentioning "ColoHealth"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ColoHealth
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- ColoHealthPMA supplement
P130001-S009 · Decided Mar 19, 2025 · 169 days after receipt · Normal 180 Day Track No User Fee
Device type: System, colorectal neoplasia, DNA methylation and hemoglobin detection (PHP) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and NeoplasiaLocal determinationIn effectL39276CGS Administrators, LLCUpdated Feb 13, 2026
- MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and NeoplasiaLocal determinationIn effectL39262Noridian Healthcare Solutions, LLCUpdated Jan 12, 2026
- MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and NeoplasiaLocal determinationIn effectL39256Palmetto GBAUpdated Mar 4, 2025
- MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and NeoplasiaLocal determinationIn effectL39356WPS Insurance CorporationUpdated Feb 20, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "ColoHealth", any status and sponsor, newest update first.
No registered device study names "ColoHealth".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ColoHealth", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PHP
33 reports: 20 malfunction, 10 injury, 1 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1077-2018 · Started Nov 2, 2017
Reason given: The diagnostic test kit may produce invalid test runs which may delay test results.
Cause as FDA categorized it: Unknown/Undetermined by firm · Device type: System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection (PHP)
Published research
The most relevant PubMed records for "ColoHealth"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PHP.
- CologuardExact Sciences Corporation · PMA 2024
- ShieldGuardant Health, Inc. · PMA 2026
- Epi proColonNew Day Diagnostics, LLC · PMA 2016
- SimpleScreen CRCFreenome, LLC · PMA 2026
- Multi-Target Stool DNA (mtsDNA) Test, Cologuard PlusExact Sciences Corporation · PMA 2024
- Cologuard Stool DNA-Based Colorectal Cancer Screening TestExact Sciences Corporation · PMA 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.